Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome® Post LB on IBS Gastrointestinal Symptoms

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A randomized, placebo-controlled, double-blind clinical study to evaluate the efficacy of two different mixes of HMO-2\'-O-fucosyllactose (HMO-2FL) + Humiome® Post LB postbiotic (postbiotic-LB) on Gastrointestinal Symptoms in individuals with Irritable Bowel Syndrome (IBS)
Epistemonikos ID: 6a257c082e9d340e22c1c761b8ccbe128d6523fb
First added on: Mar 27, 2025